BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 32550904)

  • 1. HDAC6-specific inhibitor suppresses Th17 cell function via the HIF-1α pathway in acute lung allograft rejection in mice.
    Zhou W; Yang J; Saren G; Zhao H; Cao K; Fu S; Pan X; Zhang H; Wang A; Chen X
    Theranostics; 2020; 10(15):6790-6805. PubMed ID: 32550904
    [No Abstract]   [Full Text] [Related]  

  • 2. The Critical Role of Induced CD4+ FoxP3+ Regulatory Cells in Suppression of Interleukin-17 Production and Attenuation of Mouse Orthotopic Lung Allograft Rejection.
    Zhou W; Zhou X; Gaowa S; Meng Q; Zhan Z; Liu J; Li J; Fan H; Liu Z
    Transplantation; 2015 Jul; 99(7):1356-64. PubMed ID: 25856405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8(+)IL-17(+) T Cells Mediate Neutrophilic Airway Obliteration in T-bet-Deficient Mouse Lung Allograft Recipients.
    Lendermon EA; Dodd-o JM; Coon TA; Miller HL; Ganguly S; Popescu I; O'Donnell CP; Cardenes N; Levine M; Rojas M; Weathington NM; Zhao J; Zhao Y; McDyer JF
    Am J Respir Cell Mol Biol; 2015 May; 52(5):622-33. PubMed ID: 25286244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse.
    Ropponen JO; Keränen MA; Raissadati A; Nykänen AI; Krebs R; Lemström KB; Tikkanen JM
    J Heart Lung Transplant; 2016 May; 35(5):671-8. PubMed ID: 26856676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A Is Critical for CD8+ T Effector Response in Airway Epithelial Injury After Transplantation.
    Zhang R; Fang H; Chen R; Ochando JC; Ding Y; Xu J
    Transplantation; 2018 Dec; 102(12):e483-e493. PubMed ID: 30211827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranuclear Delivery of HIF-1α-TMD Alleviates EAE
    Shin JS; Kim I; Moon JS; Ho CC; Choi MS; Ghosh S; Lee SK
    Front Immunol; 2021; 12():741938. PubMed ID: 34745114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
    Yao Y; Wang L; Zhou J; Zhang X
    J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiomyocyte-targeted HIF-1alpha gene therapy inhibits cardiomyocyte apoptosis and cardiac allograft vasculopathy in the rat.
    Keränen MA; Nykänen AI; Krebs R; Pajusola K; Tuuminen R; Alitalo K; Lemström KB
    J Heart Lung Transplant; 2010 Sep; 29(9):1058-66. PubMed ID: 20580263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin attenuates acute cardiac allograft rejection by antagonizing RORγt activity.
    Wu J; Zhou C; Chen W; Xie A; Li J; Wang S; Ye P; Wang W; Xia J
    Transplantation; 2013 Feb; 95(3):434-41. PubMed ID: 23296151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors.
    Sugimoto K; Itoh T; Takita M; Shimoda M; Chujo D; SoRelle JA; Naziruddin B; Levy MF; Shimada M; Matsumoto S
    Transpl Int; 2014 Apr; 27(4):408-15. PubMed ID: 24410777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tim-1-Fc suppresses chronic cardiac allograft rejection and vasculopathy by reducing IL-17 production.
    Shi X; Zhang M; Liu F; Wang Z; Zhang L; Cheng H; Zhang S; Fei T; Guo M; Bian J; Wang Q; Ding G
    Int J Clin Exp Pathol; 2014; 7(2):509-20. PubMed ID: 24551271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hypoxia-inducible factor-1alpha expression and C4d deposition in implantation biopsies on renal allograft.
    Kim DJ; Lee S; Kim SJ; Park SG; Kim JS; Hyun SJ; Song YS; Nam ES
    Transplant Proc; 2008 Sep; 40(7):2145-6. PubMed ID: 18790175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 deficiency promotes the generation of alloreactive Th17 cells after cardiac transplantation in mice.
    Li L; Chen X; Zhang Y; Li Q; Qi C; Fei X; Zheng F; Gong F; Fang M
    Cell Immunol; 2019 Apr; 338():9-20. PubMed ID: 30826001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockout of microRNA-155 ameliorates the Th1/Th17 immune response and tissue injury in chronic rejection.
    Zhang A; Wang K; Zhou C; Gan Z; Ma D; Ye P; Sun Y; Wu J; Huang X; Ren L; Deng P; Wu C; Yue Z; Ding X; Chen J; Xia J
    J Heart Lung Transplant; 2017 Feb; 36(2):175-184. PubMed ID: 27296836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double deficiency for RORγt and T-bet drives Th2-mediated allograft rejection in mice.
    Sabet-Baktach M; Eggenhofer E; Rovira J; Renner P; Lantow M; Farkas SA; Malaisé M; Edtinger K; Shaotang Z; Koehl GE; Dahlke MH; Schlitt HJ; Geissler EK; Kroemer A
    J Immunol; 2013 Oct; 191(8):4440-6. PubMed ID: 24058178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
    J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the purinergic pathway prolongs mouse lung allograft survival.
    Liu K; Vergani A; Zhao P; Ben Nasr M; Wu X; Iken K; Jiang D; Su X; Fotino C; Fiorina P; Visner GA
    Am J Respir Cell Mol Biol; 2014 Aug; 51(2):300-10. PubMed ID: 24661183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockage of P2X7R suppresses Th1/Th17-mediated immune responses and corneal allograft rejection via inhibiting NLRP3 inflammasome activation.
    Fan X; Zhang J; Dai Y; Shan K; Xu J
    Exp Eye Res; 2021 Nov; 212():108792. PubMed ID: 34656546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-mobility group box 1 accelerates early acute allograft rejection via enhancing IL-17+ γδ T-cell response.
    Xia Q; Duan L; Shi L; Zheng F; Gong F; Fang M
    Transpl Int; 2014 Apr; 27(4):399-407. PubMed ID: 24410759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.